Table 1 |
|
|
Conditions to consider in the differential diagnosis of urticaria. |
|
|
Urticarial vasculitis |
• Lesions are usually painful (rather than pruritic), last >48 hours, and leave discoloration on the skin |
|
|
|
|
Systemic mastocytosis |
• Rare condition that involves the internal organs (liver, spleen, lymph nodes, bone marrow), in addition to the skin |
|
|
|
|
Atopic dermatitis |
• Chronic, highly pruritic inflammatory skin disease • Clinical manifestations vary with age |
|
|
|
|
Bullous pemphigoid |
• Chronic, autoimmune, blistering skin disease |
|
|
|
|
Erythema multiforme |
• Acute, self-limited, skin condition • Considered to be a type IV hypersensitivity reaction to certain infections, medications, and other various triggers |
|
|
|
|
Familial cold autoinflammatory syndrome |
• Rare, inherited inflammatory disorder characterized by recurrent episodes of rash, fever/chills, joint pain, and other signs/symptoms of systemic inflammation triggered by exposure to cooling temperatures • Onset usually occurs during infancy and early childhood and persists throughout the patient’s life |
|
|
|
|
Fixed drug eruptions |
• Lesions occur from exposure to a particular medication and occur at the same site upon re-exposure to the offending medication • Lesions usually blister and leave residual pigmentation |
|
|
|
|
Subacute cutaneous lupus erythematosus |
• A non-scarring, photosensitive skin condition • May occur in patients with systemic lupus erythematosus (SLE) and Sjögren syndrome |
|
|
|
|
Pruritic urticarial papules and plaques of pregnancy |
• Benign skin condition that usually arises late in the third trimester of a first pregnancy |
|
|
|
|
Muckle-Wells syndrome |
• Rare genetic disease that causes hearing loss and recurrent hives • May lead to amyloidosis |
|
|
|
|
Schnitzler's syndrome with monoclonal IgG kappa gammopathy |
• Rare disease characterized by chronic, non-pruritic hives, periodic fever, bone and joint pain, swollen lymph glands and an enlarged spleen and liver |
|
|
|
|
Kanani et al. Allergy, Asthma & Clinical Immunology 2011 7(Suppl 1):S9 doi:10.1186/1710-1492-7-S1-S9 |
|